EEF1A2 Antikörper (C-Term)
Kurzübersicht für EEF1A2 Antikörper (C-Term) (ABIN7540567)
Target
Alle EEF1A2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Hersteller Produkt- Nr.
- 600-101-ml6
-
Hersteller
- Rockland
-
Verwendungszweck
- EEF1A2 Antibody
-
Kreuzreaktivität (Details)
- This affinity purified antibody is directed against human EEF1A2.
-
Aufreinigung
- The product was affinity purified from monospecific antiserum by immunoaffinity purification.
-
Sterilität
- Sterile filtered
-
Immunogen
- Anti-EEF1A2 antibody was prepared from whole goat serum produced by repeated immunizations with a synthetic peptide corresponding to a near C-terminal portion of human EEF1A2 conjugated to Keyhole Limpet Hemocyanin (KLH).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA_Dilution: 1:10,000-1:50,000
Immunohistochemistry_Dilution: 1:200
IF_Microscopy_Dilution: 15 μg/mL
Western_Blot_Dilution: 1:1000
-
Kommentare
-
Anti-EEF1A2 Antibody has been tested in WB, IF, and IHC. Expect a band at ~50.5 kDa in western blot using appropriate lysates. Positive control used: human skeletal muscle lysate, MCF-7 nuclear extract lysate in WB, MCF-7 cells in IF, and human skeletal muscle tissue in IHC.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Stabilizer: None
Preservative: 0.01 % (w/v) Sodium Azide -
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
-
Haltbarkeit
- 12 months
-
-
- EEF1A2 (Eukaryotic Translation Elongation Factor 1 alpha 2 (EEF1A2))
-
Andere Bezeichnung
- EEF1A2
-
Hintergrund
- Goat Anti-EEF1A2 Antibody, Goat Anti-Eukaryotic Translation Elongation Factor 1 Alpha 2 Antibody, Eukaryotic Elongation Factor 1 A-2, EF-1-Alpha-2, Statin-S1, EEF1AL, STN 3, Elongation Factor 1-Alpha 2, Statin-Like, EEF1A-2, EIEE33, Statin, MRD38, EF1A, STNL, HS1,EEF1A2 (Eukaryotic Translation Elongation Factor 1 Alpha 2) protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. EEF1A2 encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 2) is expressed in brain, heart and skeletal muscle, and the other isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas. EEF1A2 may be associated with the development of ovarian cancer, along with Epileptic Encephalopathy, Early Infantile, 33 and Mental Retardation, Autosomal Dominant 38. Anti-EEF1A2 Antibody is useful for researchers interested in cancer research, translation factors, GTP binding, and GTPase activities.
-
Gen-ID
- 1917
-
NCBI Accession
- NP_001949
-
UniProt
- Q05639
Target
-